PECAM-1: Conflicts of interest in inflammation
Open accessThe DOI matches its Crossref record; 109 of the 109 references it cites were found in a registry or an index.
Abstract
Platelet endothelial cell adhesion molecule-1 (PECAM-1, CD31) is a cell adhesion and signaling receptor that is expressed on hematopoietic and endothelial cells. PECAM-1 is vital to the regulation of inflammatory responses, as it has been shown to serve a variety of pro-inflammatory and anti-inflammatory functions. Pro-inflammatory functions of PECAM-1 include the facilitation of leukocyte transendothelial migration and the transduction of mechanical signals in endothelial cells emanating from fluid shear stress. Anti-inflammatory functions include the dampening of leukocyte activation, suppression of pro-inflammatory cytokine production, and the maintenance of vascular barrier integrity. Although PECAM-1 has been well-characterized and studied, the mechanisms through which PECAM-1 regulates these seemingly opposing functions, and how they influence each other, are still not completely understood. The purpose of this review, therefore, is to provide an overview of the pro- and anti-inflammatory functions of PECAM-1 with special attention paid to mechanistic insights that have thus far been revealed in the literature in hopes of gaining a clearer picture of how these opposing functions might be integrated in a temporal and spatial manner on the whole organism level. A better understanding of how inflammatory responses are regulated should enable the development of new therapeutics that can be used in the treatment of acute and chronic inflammatory disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chemokines and leukocyte traffic
Baggiolini, M. (1998) · Nature · doi:10.1038/33340 · Cited by 2,709 · cited 1×
“Chemokine gradients serve to direct leukocytes to their destination by activating integrins on the leukocyte surface and by promoting actin cycling and polymerization events at localized sites within the cell (Baggiolini 1998).”
BackgroundA mechanosensory complex that mediates the endothelial cell response to fluid shear stress
Tzima, E., Irani-Tehrani, M., Kiosses, W. B., Dejana, E., Schultz, D. A., Engelhardt, B., Cao, G., DeLisser, H., & Schwartz, M. A. (2005) · Nature · doi:10.1038/nature03952 · Cited by 1,711 · cited 15×
“This likely has implications for atherosclerotic development in areas of the vasculature exposed to disturbed shear stress as PECAM-1 can activate the proinflammatory transcription factor NF-κB downstream of mechanical activation (Tzima et al. 2005).”
BackgroundInfluentialTakeda, K., Clausen, B. E., Kaisho, T., Tsujimura, T., Terada, N., Förster, I., & Akira, S. (1999) · Immunity · doi:10.1016/s1074-7613(00)80005-9 · Cited by 1,220 · cited 1×
“…during inflammation (Alonzi et al. 2001), and although it can mediate transcription of both pro- and antiinflammatory genes, studies in cell-type specific knockout mice suggest that its antiinflammatory effects might predominate in models of inflammation (Takeda et al. 1999; Kano et al. 2003).”
BackgroundPECAM-1 is required for transendothelial migration of leukocytes.
Muller, W. A., Weigl, S. A., Deng, X., & Phillips, D. M. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.2.449 · Cited by 1,152 · cited 6×
“N IH -PA Author M anuscript N IH -PA Author M anuscript N IH -PA Author M anuscript N IH -PA Author M anuscript N IH -PA Author M anuscript N IH -PA Author M anuscript Table 1 Pro-inflammatory functions of PECAM-1 Inflammatory Model Results Mousestrain References Neutrophil chemotaxis in Zigmund chambers toward IL-8,…”
BackgroundInfluentialPECAM-1 (CD31) Cloning and Relation to Adhesion Molecules of the Immunoglobulin Gene Superfamily
Newman, P. J., Berndt, M. C., Gorski, J., White, G. C., Lyman, S., Paddock, C., & Muller, W. A. (1990) · Science · doi:10.1126/science.1690453 · Cited by 950 · cited 3×
“PECAM-1 is also highly expressed on endothelial cells, where it is a major constituent of the endothelial cell intercellular junction in confluent vascular beds (Muller et al. 1989; Albelda et al. 1990; Newman et al. 1990; Newman 1997).”
BackgroundSelf-citationAnti-inflammatory lipid mediators and insights into the resolution of inflammation
Lawrence, T., Willoughby, D. A., & Gilroy, D. W. (2002) · Nature Reviews Immunology · doi:10.1038/nri915 · Cited by 862 · cited 1×
“These cardinal signs are largely the result of two main components of inflammatory responses: (1) increased vascular permeability and (2) the emigration, accumulation, and activation of leukocytes (Lawrence et al. 2002).”
BackgroundSphingosine 1-phosphate and its receptors: an autocrine and paracrine network
Rosen, H., & Goetzl, E. J. (2005) · Nature Reviews Immunology · doi:10.1038/nri1650 · Cited by 694 · cited 7×
“Due to the importance of S1P in vascular barrier function and the ability of S1P and PECAM-1 to regulate each other, further clarity is needed to determine whether PECAM-1 can indeed promote barrier maintenance through S1P signaling.”
BackgroundInfluentialNewman, P. J. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119129 · Cited by 664 · cited 2×
“It is expressed on most cells of the hematopoietic lineage including platelets, monocytes, neutrophils, and lymphocyte subsets (Newman 1997; Newman 1999; Newman and Newman 2003).”
BackgroundSelf-citationPECAM-1: A Multi-Functional Molecule in Inflammation and Vascular Biology
Woodfin, A., Voisin, M.-B., & Nourshargh, S. (2007) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.151456 · Cited by 583
Involvement of Platelet-Endothelial Cell Adhesion Molecule-1 in Neutrophil Recruitment in Vivo
Vaporciyan, A. A., DeLisser, H. M., Yan, H.-C., Mendiguren, I. I., Thom, S. R., Jones, M. L., Ward, P. A., & Albelda, S. M. (1993) · Science · doi:10.1126/science.8248808 · Cited by 458 · cited 8×
“…immune complex deposition in lungs in rats Antibody-blockade of PECAM-1 blocked accumulation of neutrophils into the alveolar compartment N/A (Vaporciyan et al. 1993) Human skin grafts transplanted into immunodeficient mice Antibody-blockade of PECAM-1 blocked accumulation of…”
BackgroundInfluentialMolecular mechanisms of the vascular responses to haemodynamic forces
LEHOUX, S., CASTIER, Y., & TEDGUI, A. (2006) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2006.01624.x · Cited by 447 · cited 1×
“The endothelium is constantly subjected to mechanical forces such as stretch, cyclic mechanical strain, and fluid shear stress (Lehoux et al. 2006).”
BackgroundDuncan, G. S., Andrew, D. P., Takimoto, H., Kaufman, S. A., Yoshida, H., Spellberg, J., Luis de la Pompa, J., Elia, A., Wakeham, A., Karan-Tamir, B., et al. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.5.3022 · Cited by 431 · cited 5×
“N IH -PA Author M anuscript N IH -PA Author M anuscript N IH -PA Author M anuscript N IH -PA Author M anuscript N IH -PA Author M anuscript N IH -PA Author M anuscript Table 1 Pro-inflammatory functions of PECAM-1 Inflammatory Model Results Mousestrain References Neutrophil chemotaxis in Zigmund chambers toward IL-8,…”
BackgroundInfluentialThe Small Gtpase, Rap1, Mediates Cd31-Induced Integrin Adhesion
Reedquist, K. A., Ross, E., Koop, E. A., Wolthuis, R. M. F., Zwartkruis, F. J. T., van Kooyk, Y., Salmon, M., Buckley, C. D., & Bos, J. L. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.148.6.1151 · Cited by 415 · cited 2×
“Antibody-mediated ligation of PECAM-1 in Jurkat T cells was reported to activate Rap1, a Ras family GTPase, and this activation required the presence of functional ITIMs in the cytoplasmic tail of PECAM-1 (Reedquist et al. 2000).”
BackgroundEndoCAM: a novel endothelial cell-cell adhesion molecule.
Albelda, S. M., Oliver, P. D., Romer, L. H., & Buck, C. A. (1990) · The Journal of cell biology · doi:10.1083/jcb.110.4.1227 · Cited by 402 · cited 2×
“PECAM-1 is also highly expressed on endothelial cells, where it is a major constituent of the endothelial cell intercellular junction in confluent vascular beds (Muller et al. 1989; Albelda et al. 1990; Newman et al. 1990; Newman 1997).”
BackgroundNewman, P. J., & Newman, D. K. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000071347.69358.d9 · Cited by 400 · cited 20×
“The cytoplasmic tail of PECAM-1 contains residues that serve as potential sites for palmitoylation, phosphorylation, and the docking of cytosolic signaling molecules (Newman and Newman 2003).”
BackgroundInfluentialSelf-citationHuman CD38 (ADP-Ribosyl Cyclase) Is a Counter-Receptor of CD31, an Ig Superfamily Member
Deaglio, S., Morra, M., Mallone, R., Ausiello, C. M., Prager, E., Garbarino, G., Dianzani, U., Stockinger, H., & Malavasi, F. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.1.395 · Cited by 389 · cited 1×
“Other perhaps more controversial heterophilic binding partners of PECAM-1 include glycosaminoglycans (GAG) (Delisser et al. 1993; Sun et al. 1998), the integrin αVβ3 (Piali et al. 1995; Buckley et al. 1996; Sun et al. 1996), and CD38 on lymphocytes (Deaglio et al. 1998).”
BackgroundPiali, L., Hammel, P., Uherek, C., Bachmann, F., Gisler, R. H., Dunon, D., & Imhof, B. A. (1995) · The Journal of cell biology · doi:10.1083/jcb.130.2.451 · Cited by 376 · cited 2×
“Other perhaps more controversial heterophilic binding partners of PECAM-1 include glycosaminoglycans (GAG) (Delisser et al. 1993; Sun et al. 1998), the integrin αVβ3 (Piali et al. 1995; Buckley et al. 1996; Sun et al. 1996), and CD38 on lymphocytes (Deaglio et al. 1998).”
BackgroundTanaka, Y., Albelda, S. M., Horgan, K. J., van Seventer, G. A., Shimizu, Y., Newman, W., Hallam, J., Newman, P. J., Buck, C. A., & Shaw, S. (1992) · The Journal of experimental medicine · doi:10.1084/jem.176.1.245 · Cited by 372 · cited 2×
“Leukocyte integrins reported to be activated downstream of PECAM-1 ligation include the β1- and β2-integrins in T cell subsets (Tanaka et al. 1992), β1integrins in macrophages (Vernon-Wilson et al. 2006; Vernon-Wilson et al. 2007), β2integrins in natural killer (NK) cells (Berman et al. 1996), and…”
BackgroundSelf-citationMuller, W. A., Ratti, C. M., McDonnell, S. L., & Cohn, Z. A. (1989) · The Journal of experimental medicine · doi:10.1084/jem.170.2.399 · Cited by 358 · cited 2×
“PECAM-1 is also highly expressed on endothelial cells, where it is a major constituent of the endothelial cell intercellular junction in confluent vascular beds (Muller et al. 1989; Albelda et al. 1990; Newman et al. 1990; Newman 1997).”
BackgroundHuang, A. J., Manning, J. E., Bandak, T. M., Ratau, M. C., Hanser, K. R., & Silverstein, S. C. (1993) · The Journal of cell biology · doi:10.1083/jcb.120.6.1371 · Cited by 339 · cited 1×
“…signaling pathways that lead to a rise in intracellular calcium ion concentration (Gurubhagavatula et al. 1998; O’Brien et al. 2001), which helps initiate signaling pathways that open up intercellular junctions and allow leukocytes to transit across the endothelial monolayer (Huang et al. 1993).”
BackgroundAlonzi, T., Maritano, D., Gorgoni, B., Rizzuto, G., Libert, C., & Poli, V. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.5.1621-1632.2001 · Cited by 329 · cited 1×
“STAT3 is known to be important in the regulation of the acute phase response during inflammation (Alonzi et al. 2001), and although it can mediate transcription of both pro- and antiinflammatory genes, studies in cell-type specific knockout mice suggest that its antiinflammatory effects might…”
BackgroundTargeted recycling of PECAM from endothelial surface-connected compartments during diapedesis
Mamdouh, Z., Chen, X., Pierini, L. M., Maxfield, F. R., & Muller, W. A. (2003) · Nature · doi:10.1038/nature01300 · Cited by 317 · cited 16×
“Later work by this same group demonstrated that both PECAM-1-dependent and PECAM-1-independent leukocyte transmigration is dependent on LBRC recycling mediated by endothelial microtubules and kinesin family molecular motors (Mamdouh et al. 2008).”
BackgroundInfluentialOsawa, M., Masuda, M., Kusano, K.-I., & Fujiwara, K. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200205049 · Cited by 307 · cited 4×
“[PubMed: 12397602] Wang Y, Sheibani N. PECAM-1 isoform-specific activation of MAPK/ERKs and small GTPases: implications in inflammation and angiogenesis.”
BackgroundInfluentialLeukocyte-Endothelial Cell Interactions in the Inflammatory Response
Muller, W. A. (2002) · Laboratory Investigation · doi:10.1038/labinvest.3780446 · Cited by 304 · cited 1×
“In order to home to the site of injury or infection, leukocytes go through the well-established leukocyte adhesion cascade, which ends when they transmigrate across the endothelium in order to enter extravascular tissues in a process termed leukocyte diapedesis (Muller 2002).”
BackgroundMonoclonal antibody to murine PECAM-1 (CD31) blocks acute inflammation in vivo.
Bogen, S., Pak, J., Garifallou, M., Deng, X., & Muller, W. A. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.3.1059 · Cited by 295 · cited 3×
“…peritonitis in mice Antibody-blockade of PECAM-1 prevented accumulation of neutrophils into the peritoneal cavity AKR/J, CD2F1 (Bogen et al. 1994) IgG immune complex deposition in lungs in rats Antibody-blockade of PECAM-1 blocked accumulation of neutrophils into the alveolar…”
BackgroundBaldwin, H. S., Shen, H. M., Yan, H.-C., DeLisser, H. M., Chung, A., Mickanin, C., Trask, T., Kirschbaum, N. E., Newman, P. J., Albelda, S. M., et al. (1994) · Development · doi:10.1242/dev.120.9.2539 · Cited by 294
Self-citationGraesser, D., Solowiej, A., Bruckner, M., Osterweil, E., Juedes, A., Davis, S., Ruddle, N. H., Engelhardt, B., & Madri, J. A. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0213595 · Cited by 273 · cited 12×
“…Newman 1999;Newman et al. 2001;Wilkinson et al. 2002;Wong et al. 2002;Rui et al. 2007), (2) helping to maintain and restore the vascular barrier (Graesser et al. 2002;Carrithers et al. 2005;Maas et al. 2005), and (3) dampening production of pro-inflammatory cytokines (Tada et al.…”
BackgroundInfluentialSwitched at birth: a new family for PECAM-1
Newman, P. J. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5928 · Cited by 257 · cited 4×
“It is expressed on most cells of the hematopoietic lineage including platelets, monocytes, neutrophils, and lymphocyte subsets (Newman 1997; Newman 1999; Newman and Newman 2003).”
BackgroundInfluentialSelf-citationSachs, U. J. H., Andrei-Selmer, C. L., Maniar, A., Weiss, T., Paddock, C., Orlova, V. V., Choi, E. Y., Newman, P. J., Preissner, K. T., Chavakis, T., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m701120200 · Cited by 241
Self-citationLiao, F., Huynh, H. K., Eiroa, A., Greene, T., Polizzi, E., & Muller, W. A. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.5.1337 · Cited by 237 · cited 2×
“…mechanisms by which PECAM-1 promotes these processes is through homophilic PECAM-1/PECAM-1 adhesive interactions between leukocytes and endothelial cells as they traverse the endothelial cell-cell junction (Muller et al. 1993; Liao et al. 1995; Liao et al. 1997; Nakada et al. 2000).”
BackgroundDangerfield, J., Larbi, K. Y., Huang, M.-T., Dewar, A., & Nourshargh, S. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020324 · Cited by 234 · cited 4×
“…within endothelial cells to promote leukocyte transmigration, and also if heterotypic CD177/PECAM-1 interactions promote integrin activation in leukocytes as do homotypic interactions (Tanaka et al. 1992; Berman and Muller 1995; Berman et al. 1996; Dangerfield et al. 2002; Wang et al. 2005).”
BackgroundInfluentialCellular functions of the Rap1 GTP-binding protein: a pattern emerges
Caron, E. (2003) · Journal of Cell Science · doi:10.1242/jcs.00238 · Cited by 215
Woodfin, A., Voisin, M.-B., Imhof, B. A., Dejana, E., Engelhardt, B., & Nourshargh, S. (2009) · Blood · doi:10.1182/blood-2008-11-188375 · Cited by 213 · cited 5×
“…through the cell-cell junction and across the basement membrane C57BL/6J (Thompson et al. 2001; Dangerfield et al. 2002; Wang et al. 2005; Woodfin et al. 2009) Thioglycollate-induced peritonitis PECAM-1 promotes leukocyte emigration tothe peritoneum FVBn, Swiss Webster (Schenkel et al.…”
BackgroundInfluentialMolecular characterization and functional analysis of the leukocyte surface protein CD31.
Stockinger, H., Gadd, S. J., Eher, R., Majdic, O., Schreiber, W., Kasinrerk, W., Strass, B., Schnabl, E., & Knapp, W. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.145.11.3889 · Cited by 209 · cited 1×
“…roles for PECAM-1: facilitation of leukocyte transendothelial migration After PECAM-1 was cloned and characterized in 1990 (Newman et al. 1990; Stockinger et al. 1990; Simmons et al. 1990), many of the early studies of the biological functions of PECAM-1 were focused on its pro-inflammatory…”
BackgroundEndothelial cell tube formation depends on cadherin 5 and CD31 interactions with filamentous actin
Matsumura, T., Wolff, K., & Petzelbauer, P. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.7.3408 · Cited by 206 · cited 1×
“PECAM-1 has been reported to bind, maintain the de-phosphorylated (barrier protective) state, and enhance the stability of catenins, which has been correlated with PECAM-1-mediated vascular barrier enhancement (Matsumura et al. 1997; Biswas et al. 2003; Biswas et al. 2005; Biswas et al. 2006).”
BackgroundIdentification of αvβ3 as a heterotypic ligand for CD31/PECAM-1
Buckley, C. D., Doyonnas, R., Newton, J. P., Blystone, S. D., Brown, E. J., Watt, S. M., & Simmons, D. L. (1996) · Journal of Cell Science · doi:10.1242/jcs.109.2.437 · Cited by 197
Dual Regulation of Endothelial Junctional Permeability
Komarova, Y. A., Mehta, D., & Malik, A. B. (2007) · Science's STKE · doi:10.1126/stke.4122007re8 · Cited by 195 · cited 2×
“An alternative, and potentially attractive mechanism for PECAM-1-mediated barrier maintenance is via modulation of signaling by sphingosine-1-phosphate (S1P), which is known to promote vascular barrier function through adherens junction assembly (Komarova et al. 2007).”
BackgroundThompson, R. D., Noble, K. E., Larbi, K. Y., Dewar, A., Duncan, G. S., Mak, T. W., & Nourshargh, S. (2001) · Blood · doi:10.1182/blood.v97.6.1854 · Cited by 187 · cited 5×
“N IH -PA Author M anuscript N IH -PA Author M anuscript N IH -PA Author M anuscript N IH -PA Author M anuscript N IH -PA Author M anuscript N IH -PA Author M anuscript Table 1 Pro-inflammatory functions of PECAM-1 Inflammatory Model Results Mousestrain References Neutrophil chemotaxis in Zigmund chambers toward IL-8,…”
BackgroundInfluentialLiao, F., Ali, J., Greene, T., & Muller, W. A. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.7.1349 · Cited by 185 · cited 1×
“…mechanisms by which PECAM-1 promotes these processes is through homophilic PECAM-1/PECAM-1 adhesive interactions between leukocytes and endothelial cells as they traverse the endothelial cell-cell junction (Muller et al. 1993; Liao et al. 1995; Liao et al. 1997; Nakada et al. 2000).”
BackgroundMamdouh, Z., Mikhailov, A., & Muller, W. A. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20082745 · Cited by 185 · cited 3×
“…a surface connected membrane compartment, that promotes both paracellular and transcellular migration N/A (Mamdouh et al. 2003; Mamdouh et al. 2008; Mamdouh et al. 2009; Dasgupta et al. 2009) EAE Short-term administration of chimeric soluble PECAM-1 fused to human IgG-Fc (PECAM-Fc)decreased…”
BackgroundDeLisser, H. M., Yan, H. C., Newman, P. J., Muller, W. A., Buck, C. A., & Albelda, S. M. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)82354-7 · Cited by 180 · cited 3×
“Other perhaps more controversial heterophilic binding partners of PECAM-1 include glycosaminoglycans (GAG) (Delisser et al. 1993; Sun et al. 1998), the integrin αVβ3 (Piali et al. 1995; Buckley et al. 1996; Sun et al. 1996), and CD38 on lymphocytes (Deaglio et al. 1998).”
BackgroundSelf-citationBerman, M. E., Xie, Y., & Muller, W. A. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.4.1515 · Cited by 179 · cited 2×
“…within endothelial cells to promote leukocyte transmigration, and also if heterotypic CD177/PECAM-1 interactions promote integrin activation in leukocytes as do homotypic interactions (Tanaka et al. 1992; Berman and Muller 1995; Berman et al. 1996; Dangerfield et al. 2002; Wang et al. 2005).”
BackgroundOsawa, M., Masuda, M., Harada, N., Lopes, R., & Fujiwara, K. (1997) · PubMed · Cited by 177
Limaye, V., Li, X., Hahn, C., Xia, P., Berndt, M. C., Vadas, M. A., & Gamble, J. R. (2005) · Blood · doi:10.1182/blood-2004-02-0452 · Cited by 177 · cited 1×
“PECAM-1 has been shown to interact with Sphk in transfected cells and modulate its function (Fukuda et al. 2004; Limaye et al. 2005), suggesting that PECAM-1 might regulate S1P signaling upstream of S1P binding to its cell surface receptors.”
BackgroundSun, Q.-H., DeLisser, H. M., Zukowski, M. M., Paddock, C., Albelda, S. M., & Newman, P. J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.19.11090 · Cited by 174 · cited 3×
“Other perhaps more controversial heterophilic binding partners of PECAM-1 include glycosaminoglycans (GAG) (Delisser et al. 1993; Sun et al. 1998), the integrin αVβ3 (Piali et al. 1995; Buckley et al. 1996; Sun et al. 1996), and CD38 on lymphocytes (Deaglio et al. 1998).”
BackgroundSelf-citationRap1 GTPase Inhibits Leukocyte Transmigration by Promoting Endothelial Barrier Function
Wittchen, E. S., Worthylake, R. A., Kelly, P., Casey, P. J., Quilliam, L. A., & Burridge, K. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m412595200 · Cited by 168 · cited 1×
“Rap1 is important for restoring barrier function in endothelial cells through accelerated assembly of endothelial cell-cell junctions (Wittchen et al. 2005).”
BackgroundMohan, S., Mohan, N., & Sprague, E. A. (1997) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1997.273.2.c572 · Cited by 165 · cited 1×
“In contrast, in regions of oscillatory or disturbed flow, which occur at vessel bifurcations and in regions of high curvature, endothelial cells are unable to adapt to shear stresses and therefore activate pro-inflammatory signaling pathways without compensatory downregulation (Mohan et al. 1997).”
BackgroundEndothelial Cells Require STAT3 for Protection against Endotoxin-induced Inf lammation
Kano, A., Wolfgang, M. J., Gao, Q., Jacoby, J., Chai, G.-X., Hansen, W., Iwamoto, Y., Pober, J. S., Flavell, R. A., & Fu, X.-Y. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030077 · Cited by 163 · cited 1×
“…during inflammation (Alonzi et al. 2001), and although it can mediate transcription of both pro- and antiinflammatory genes, studies in cell-type specific knockout mice suggest that its antiinflammatory effects might predominate in models of inflammation (Takeda et al. 1999; Kano et al. 2003).”
BackgroundBerman, M. E., & Muller, W. A. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.1.299 · Cited by 161 · cited 2×
“…within endothelial cells to promote leukocyte transmigration, and also if heterotypic CD177/PECAM-1 interactions promote integrin activation in leukocytes as do homotypic interactions (Tanaka et al. 1992; Berman and Muller 1995; Berman et al. 1996; Dangerfield et al. 2002; Wang et al. 2005).”
BackgroundAgonist-modulated Targeting of the EDG-1 Receptor to Plasmalemmal Caveolae
Igarashi, J., & Michel, T. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003075200 · Cited by 160 · cited 1×
“Localization of S1P receptors to membrane microdomains has been found to be important for their signaling functions (Igarashi and Michel 2000).”
BackgroundSimmons, D. L., Walker, C., Power, C., & Pigott, R. (1990) · The Journal of experimental medicine · doi:10.1084/jem.171.6.2147 · Cited by 160
The role of JAM-A and PECAM-1 in modulating leukocyte infiltration in inflamed and ischemic tissues
Nourshargh, S., Krombach, F., & Dejana, E. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.1105645 · Cited by 154 · cited 2×
“PECAM-1 is known to exert effects on both leukocytes and endothelial cells at both early and late stages of the leukocyte adhesion cascade (Nourshargh et al. 2006; Woodfin et al. 2007).”
BackgroundNewton-Nash, D. K., & Newman, P. J. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.2.682 · Cited by 153 · cited 14×
“Other SH2 domain-containing proteins that have been reported to associate with phosphorylated PECAM-1 ITIMs, include members of the Src family of tyrosine kinases (SFK) (Lu et al. 1997; Masuda et al. 1997; Osawa et al. 1997), SHP-1 (Hua et al. 1998; Henshall et al. 2001), SH2 domain-containing inositol 5’-phosphatase…”
BackgroundInfluentialSelf-citationSchenkel, A. R., Chew, T. W., & Muller, W. A. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.10.6403 · Cited by 153 · cited 6×
“…Wang et al. 2005; Woodfin et al. 2009) Thioglycollate-induced peritonitis PECAM-1 promotes leukocyte emigration tothe peritoneum FVBn, Swiss Webster (Schenkel et al. 2004) Croton oil-induced topical dermatitis PECAM-1 helps neutrophils extravasate FVBn (Schenkel et al. 2004) Foreign body implant…”
BackgroundInfluentialHarry, B. L., Sanders, J. M., Feaver, R. E., Lansey, M., Deem, T. L., Zarbock, A., Bruce, A. C., Pryor, A. W., Gelfand, B. D., Blackman, B. R., et al. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.164707 · Cited by 151 · cited 5×
“PECAM-1-mediated promotion of atherosclerotic lesion development was further confirmed in two other independent studies (Harry et al. 2008; Stevens et al. 2008).”
BackgroundResultInfluentialEnhanced Susceptibility to Endotoxic Shock and Impaired STAT3 Signaling in CD31-Deficient Mice
Carrithers, M. D., Tandon, S., Canosa, S., Michaud, M., Graesser, D., & Madri, J. A. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62243-2 · Cited by 139 · cited 27×
“…2005), late-stage autoimmunity (Wilkinson et al. 2002), autoimmune encephalitis (Graesser et al. 2002), lipopolysaccharide (LPS)-induced endotoxic shock (Maas et al. 2005;Carrithers et al. 2005), atherogenic diet-induced steatohepatitis (Goel et al. 2007), and atherosclerosis (Goel et al. 2008).”
BackgroundInfluentialNewton, J. P., Buckley, C. D., Jones, E. Y., & Simmons, D. L. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.33.20555 · Cited by 131 · cited 1×
“1) (Sun et al. 1996; Newton et al. 1997).”
Newman, D. K., Hamilton, C., & Newman, P. J. (2001) · Blood · doi:10.1182/blood.v97.8.2351 · Cited by 130 · cited 17×
“…(1) raising the threshold for leukocyte activation as a consequence of its function as an inhibitory receptor (Newton-Nash and Newman 1999;Newman et al. 2001;Wilkinson et al. 2002;Wong et al. 2002;Rui et al. 2007), (2) helping to maintain and restore the vascular barrier (Graesser et al.…”
BackgroundInfluentialSelf-citationWilkinson, R., Lyons, A. B., Roberts, D., Wong, M.-X., Bartley, P. A., & Jackson, D. E. (2002) · Blood · doi:10.1182/blood-2002-01-0027 · Cited by 129 · cited 8×
“In support of PECAM-1 as an inhibitory receptor in lymphocytes, PECAM-1−/− mice exhibit aberrant proliferation and activation of B cells, which correlates with development of autoimmune disease in older mice (Wilkinson et al. 2002).”
BackgroundInfluentialGoldberger, A., Middleton, K. A., Oliver, J. A., Paddock, C. M., Yan, H. C., DeLisser, H. M., Albelda, S. Μ., & Newman, P. J. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32538-3 · Cited by 115 · cited 1×
“…splicing of the PECAM-1 cytoplasmic and transmembrane domains results in the production of numerous PECAM-1 isoforms, including a soluble form (Goldberger et al. 1994) and various isoforms that lack one or more cytoplasmic exons (Kirschbaum et al. 1994; Baldwin et al. 1994; Yan et al. 1995;…”
BackgroundSelf-citationHua, C. T., Gamble, J. R., Vadas, M. A., & Jackson, D. E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.43.28332 · Cited by 115 · cited 5×
“Other SH2 domain-containing proteins that have been reported to associate with phosphorylated PECAM-1 ITIMs, include members of the Src family of tyrosine kinases (SFK) (Lu et al. 1997; Masuda et al. 1997; Osawa et al. 1997), SHP-1 (Hua et al. 1998; Henshall et al. 2001), SH2 domain-containing inositol 5’-phosphatase…”
BackgroundInfluentialMamdouh, Z., Kreitzer, G. E., & Muller, W. A. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20072328 · Cited by 114 · cited 3×
“Since PECAM-1-dependent leukocyte transmigration requires Y663-mediated targeted recycling of PECAM-1 and the LBRC (Mamdouh et al. 2003; Mamdouh et al. 2008; Mamdouh et al. 2009), however, it is likely that this residue or other residues within the cytoplasmic tail of PECAM-1 serve as docking sites…”
BackgroundPECAM-1 Is Necessary for Flow-Induced Vascular Remodeling
Chen, Z., & Tzima, E. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.109.186692 · Cited by 108 · cited 1×
“Accordingly, mice that express PECAM-1 are able to transduce signals in response to mechanical force and activate NF-κB, which results in the transcription of pro-inflammatory genes at regions of disturbed flow (Tzima et al. 2005) and subsequently induces vascular remodeling (Chen and Tzima 2009).”
Site-Specific Effects of PECAM-1 on Atherosclerosis in LDL Receptor–Deficient Mice
Goel, R., Schrank, B. R., Arora, S., Boylan, B., Fleming, B., Miura, H., Newman, P. J., Molthen, R. C., & Newman, D. K. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.172270 · Cited by 107 · cited 24×
“…2005), late-stage autoimmunity (Wilkinson et al. 2002), autoimmune encephalitis (Graesser et al. 2002), lipopolysaccharide (LPS)-induced endotoxic shock (Maas et al. 2005;Carrithers et al. 2005), atherogenic diet-induced steatohepatitis (Goel et al. 2007), and atherosclerosis (Goel et al. 2008).”
BackgroundResultInfluentialSelf-citationSolowiej, A., Biswas, P., Graesser, D., & Madri, J. A. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63890-4 · Cited by 106 · cited 14×
“To further investigate these unexpected findings, Schenkel, et al. backcrossed C57BL/6 PECAM-1 knockout mice onto the FVB/n strain, and they showed that these mice did display defects in leukocyte emigration following thioglycollate-induced peritonitis and croton oil-induced topical dermatitis (Schenkel et al. 2004).”
InfluentialEndothelial cell PECAM-1 confers protection against endotoxic shock
Maas, M., Stapleton, M. A., Bergom, C. R., Mattson, D. L., Newman, D. K., & Newman, P. J. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00500.2004 · Cited by 105 · cited 8×
“…2005), late-stage autoimmunity (Wilkinson et al. 2002), autoimmune encephalitis (Graesser et al. 2002), lipopolysaccharide (LPS)-induced endotoxic shock (Maas et al. 2005;Carrithers et al. 2005), atherogenic diet-induced steatohepatitis (Goel et al. 2007), and atherosclerosis (Goel et al. 2008).”
BackgroundInfluentialSelf-citationRegulation of endotoxin-induced keratitis by PECAM-1, MIP-2, and toll-like receptor 4.
Khatri, S., Lass, J. H., Heinzel, F. P., Petroll, W. M., Gomez, J. C., Diaconu, E., Kalsow, C. Μ., & Pearlman, E. M. (2002) · PubMed · Cited by 102
Pumphrey, N. J., Taylor, V., Freeman, S., Douglas, M. R., Bradfield, P. F., Young, S. P., Lord, J. M., Wakelam, M. J. O., Bird, I. N., Salmon, M., et al. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00446-9 · Cited by 102 · cited 3×
“Pumphrey NJ, Taylor V, Freeman S, Douglas MR, Bradfield PF, Young SP, Lord JM, Wakelam MJ, Bird IN, Salmon M, Buckley CD. Differential association of cytoplasmic signalling molecules SHP-1, SHP-2, SHIP and phospholipase C-gamma1 with PECAM-1/CD31.”
BackgroundMasuda, M., Osawa, M., Shigematsu, H., Harada, N., & Fujiwara, K. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00457-2 · Cited by 102 · cited 1×
“…that have been reported to associate with phosphorylated PECAM-1 ITIMs, include members of the Src family of tyrosine kinases (SFK) (Lu et al. 1997; Masuda et al. 1997; Osawa et al. 1997), SHP-1 (Hua et al. 1998; Henshall et al. 2001), SH2 domain-containing inositol 5’-phosphatase (SHIP) (Pumphrey…”
BackgroundLu, T. T., Barreuther, M., Davis, S., & Madri, J. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.22.14442 · Cited by 102 · cited 4×
“Downstream of its cell surface receptor, S1P was reported to induce the phosphorylation of PECAM-1 in a Gαi- and SFK-dependent manner, though S1P-mediated phosphorylation of PECAM-1 was not correlated with enhanced vascular barrier function (Huang et al. 2008).”
BackgroundInfluentialPECAM-1, α6 integrins and neutrophil elastase cooperate in mediating neutrophil transmigration
Wang, S., Dangerfield, J. P., Young, R. E., & Nourshargh, S. (2005) · Journal of Cell Science · doi:10.1242/jcs.02340 · Cited by 100 · cited 3×
“…leukocytes transmigrate through the cell-cell junction and across the basement membrane C57BL/6J (Thompson et al. 2001; Dangerfield et al. 2002; Wang et al. 2005; Woodfin et al. 2009) Thioglycollate-induced peritonitis PECAM-1 promotes leukocyte emigration tothe peritoneum FVBn, Swiss Webster…”
BackgroundHenshall, T. L., Jones, K. L., Wilkinson, R., & Jackson, D. E. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.5.3098 · Cited by 94 · cited 1×
“…ITIMs, include members of the Src family of tyrosine kinases (SFK) (Lu et al. 1997; Masuda et al. 1997; Osawa et al. 1997), SHP-1 (Hua et al. 1998; Henshall et al. 2001), SH2 domain-containing inositol 5’-phosphatase (SHIP) (Pumphrey et al. 1999), and phospholipase Cγ1 (PLCγ1) (Pumphrey et al.…”
BackgroundPECAM-1 Affects GSK-3β-Mediated β-Catenin Phosphorylation and Degradation
Biswas, P., Canosa, S., Schoenfeld, D. A., Schoenfeld, J. D., Li, P., Cheas, L., Zhang, J. C., Cordova, A., Sumpio, B. E., & Madri, J. A. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.051112 · Cited by 93
Gumina, R. J., Schultz, J. E. J., Yao, Z., et al. (1996) · Circulation · doi:10.1161/01.cir.94.12.3327 · Cited by 91 · cited 1×
“…significantly reduced ischemia-reperfusion injury in rats by preventing the accumulation of neutrophils in the myocardium following ischemic injury (Gumina et al. 1996); attenuated the severity of experimental autoimmune encephalitis (EAE) following short-term administration (Reinke et al. 2007);…”
BackgroundRobson, P., Stein, P., Zhou, B., Schultz, R. M., & Baldwin, H. S. (2001) · Developmental Biology · doi:10.1006/dbio.2001.0274 · Cited by 90 · cited 1×
“…cytoplasmic exons (Kirschbaum et al. 1994; Baldwin et al. 1994; Yan et al. 1995; Sheibani et al. 1997; Sheibani et al. 1999; Sheibani et al. 2000; Robson et al. 2001; Wang and Sheibani 2002; Wu and Sheibani 2003; Wang et al. 2003a; Wang et al. 2003b; Wang et al. 2004; Bergom et al. 2008; Dimaio…”
BackgroundSun, J., Paddock, C. M., Shubert, J., Zhang, H., Amin, K. M., Newman, P. J., & Albelda, S. Μ. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.8.1459 · Cited by 88
Self-citationGurubhagavatula, I., Amrani, Y., Praticò, D., Ruberg, F. L., Albelda, S. Μ., & Panettieri, R. (1998) · Journal of Clinical Investigation · doi:10.1172/jci269 · Cited by 84 · cited 1×
“Endothelial PECAM-1 engagement may trigger signaling pathways that lead to a rise in intracellular calcium ion concentration (Gurubhagavatula et al. 1998; O’Brien et al. 2001), which helps initiate signaling pathways that open up intercellular junctions and allow leukocytes to transit across the…”
BackgroundSheibani, N., Newman, P. J., & Frazier, W. A. (1997) · Molecular Biology of the Cell · doi:10.1091/mbc.8.7.1329 · Cited by 82 · cited 24×
“Other SH2 domain-containing proteins that have been reported to associate with phosphorylated PECAM-1 ITIMs, include members of the Src family of tyrosine kinases (SFK) (Lu et al. 1997; Masuda et al. 1997; Osawa et al. 1997), SHP-1 (Hua et al. 1998; Henshall et al. 2001), SH2 domain-containing inositol 5’-phosphatase…”
BackgroundInfluentialSelf-citationFerrero, E., Ferrero, M. E., Pardi, R., & Zocchi, M. R. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)01110-z · Cited by 81 · cited 1×
“…indication that PECAM-1 was important for maintenance of the vascular barrier was demonstrated by Ferrero, et al., who showed that a blocking antibody directed against PECAM-1 increased the permeability of endothelial monolayers in vitro and of multiple vascular beds in vivo (Ferrero et al. 1995).”
BackgroundPellegatta, F., Chierchia, S. L., & Zocchi, M. R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.43.27768 · Cited by 80 · cited 7×
“We also found that higher levels of PECAM-1 expression do not correlate with lower levels of NF-κB transcriptional activity in cytokine-stimulated HEK293 cells containing an NF-κB luciferase reporter plasmid, nor do they prevent the upregulation of ICAM-1, an NF-κB target gene, in cytokine-stimulated endothelial cells…”
BackgroundInfluentialGöhring, K., Wolff, J., Doppl, W., Schmidt, K. L., Fenchel, K., Pralle, H., Sibelius, U., & Bux, J. (2004) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.05027.x · Cited by 80 · cited 2×
“Since CD177 has been shown to be upregulated in severe bacterial infections (Gohring et al. 2004), after granulocyte-colony stimulating factor (G-CSF) stimulation (Gohring et al. 2004), and in pathological conditions in newborns (Wolff et al. 2006), it remains to be determined whether the…”
BackgroundO’Brien, C. D., Lim, P. N., Sun, J., & Albelda, S. Μ. (2003) · Blood · doi:10.1182/blood-2002-08-2396 · Cited by 76
Overview: Temporal and Spatial Relationships in Shear Stress-Mediated Endothelial Signalling
Davies, P. F. (2008) · Journal of Vascular Research · doi:10.1159/000159224 · Cited by 75 · cited 3×
“As such, unidirectional or laminar shear stress is thought to be atheroprotective (Davies 1997).”
BackgroundPECAM-1 is a critical mediator of atherosclerosis
Stevens, H. Y., Melchior, B., Bell, K. S., Yun, S., Yeh, J., & Frangos, J. A. (2008) · Disease Models & Mechanisms · doi:10.1242/dmm.000547 · Cited by 71
Alonzi, T., Maritano, D., Gorgoni, B., Rizzuto, G., Libert, C., & Poli, V. (2001) · Molecular and Cellular Biology · Cited by 64
PECAM-1 isoform-specific regulation of kidney endothelial cell migration and capillary morphogenesis
Kondo, S., Scheef, E. A., Sheibani, N., & Sorenson, C. M. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00489.2006 · Cited by 59 · cited 1×
“…leukocyte-endothelial cell adhesion, leukocyte diapedesis, endothelial junctional stability, and cell survival in both murine and human cells (Sheibani et al. 1997; Sheibani et al. 2000; Wang et al. 2003a; Wang and Sheibani 2006; Kondo et al. 2007; Dimaio and Sheibani 2008; Bergom et al. 2008).”
BackgroundWong, M.-X., Roberts, D., Bartley, P. A., & Jackson, D. E. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.12.6455 · Cited by 57 · cited 6×
“PECAM-1 suppresses mast cell activation, which prevents systemic and local IgE-dependent anaphylactic reactions when animals are challenged with allergic stimuli (Wong et al. 2002).”
BackgroundInfluentialDasgupta, B., Dufour, E., Mamdouh, Z., & Müller, W. A. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803192 · Cited by 55 · cited 12×
“Later work by this same group demonstrated that both PECAM-1-dependent and PECAM-1-independent leukocyte transmigration is dependent on LBRC recycling mediated by endothelial microtubules and kinesin family molecular motors (Mamdouh et al. 2008).”
BackgroundResultInfluentialTada, Y., Koarada, S., Morito, F., Ushiyama, O., Haruta, Y., Kanegae, F., Ohta, A., Ho, A., Mak, T. W., & Nagasawa, K. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11268 · Cited by 54 · cited 19×
“…of clinically-relevant acute and chronic inflammatory conditions in C57BL/6 mice (summarized in Table 2), including collagen-induced arthritis (Tada et al. 2003;Wong et al. 2005), late-stage autoimmunity (Wilkinson et al. 2002), autoimmune encephalitis (Graesser et al. 2002),…”
BackgroundInfluentialPECAM-1 Ligation Negatively Regulates TLR4 Signaling in Macrophages
Rui, Y., Liu, X., Li, N., Jiang, Y., Chen, G., Cao, X., & Wang, J. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.11.7344 · Cited by 53
Wu, J., & Sheibani, N. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10600 · Cited by 50 · cited 2×
“…preferentially expressed early in vascular development, and replaced later by isoforms lacking exon 14 (Sheibani et al. 1997; Sheibani et al. 2000; Wu and Sheibani 2003); or to modulate the spatio-temporal disruption of adherens junctions downstream of PECAM-1 homophilic interactions during…”
BackgroundPECAM-1 promotes β-catenin accumulation and stimulates endothelial cell proliferation
Biswas, P., Canosa, S., Schoenfeld, J. D., Schoenfeld, D. A., Tucker, A., & Madri, J. A. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00313-9 · Cited by 48 · cited 1×
“PECAM-1 has been reported to bind, maintain the de-phosphorylated (barrier protective) state, and enhance the stability of catenins, which has been correlated with PECAM-1-mediated vascular barrier enhancement (Matsumura et al. 1997; Biswas et al. 2003; Biswas et al. 2005; Biswas et al. 2006).”
BackgroundPMN transendothelial migration decreases nuclear NFκB in IL-1β–activated endothelial cells
Cepinskas, G., Savickienė, J., Ionescu, C. V., & Kvietys, P. R. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200212048 · Cited by 47 · cited 1×
“…of NF-κB translocation to the nucleus by PECAM-1 initiates a negative feedback loop that prevents excessive leukocyte recruitment to sites of inflammation by dampening the NF-κBdependent expression of pro-inflammatory adhesion molecules on the endothelial cell surface (Cepinskas et al. 2003).”
BackgroundWong, M.-X., Hayball, J. D., Hogarth, P. M., & Jackson, D. E. (2005) · Journal of Clinical Immunology · doi:10.1007/s10875-005-0354-7 · Cited by 47 · cited 2×
“…with decreased proinflammatory cytokine production and leukocyte infiltration into joints compared to PECAM-1−/− mice C57BL/6J (Tada et al., 2003;Wong et al., 2005) Experimental autoimmune encephalitis (EAE) Expression of PECAM-1 delays the onset of EAE, decreases parenchymal inflammatory…”
BackgroundGoel, R., Boylan, B., Gruman, L. M., Newman, P. J., North, P. E., & Newman, D. K. (2007) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00157.2007 · Cited by 46 · cited 18×
“…2005), late-stage autoimmunity (Wilkinson et al. 2002), autoimmune encephalitis (Graesser et al. 2002), lipopolysaccharide (LPS)-induced endotoxic shock (Maas et al. 2005;Carrithers et al. 2005), atherogenic diet-induced steatohepatitis (Goel et al. 2007), and atherosclerosis (Goel et al. 2008).”
BackgroundInfluentialSelf-citationOtte, L. A., Bell, K. S., Loufrani, L., Yeh, J., Melchior, B., Dao, D. N., Stevens, H. Y., White, C. R., & Frangos, J. A. (2009) · The Journal of Physiology · doi:10.1113/jphysiol.2009.172643 · Cited by 43
PECAM‐1 engagement counteracts ICAM‐1‐induced signaling in brain vascular endothelial cells2
Couty, J., Rampon, C., Leveque, M., Laran‐Chich, M., Bourdoulous, S., Greenwood, J., & Couraud, P. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04782.x · Cited by 42 · cited 2×
“Couty, et al. demonstrated that PECAM-1 ligation with monoclonal antibodies counteracted ICAM-1 ligation-induced endothelial activation and cytoskeletal rearrangement, which is thought to promote junctional opening and leukocyte transit (Couty et al. 2007).”
BackgroundSheibani, N., Sorenson, C. M., & Frazier, W. A. (2000) · Molecular Biology of the Cell · doi:10.1091/mbc.11.8.2793 · Cited by 39 · cited 5×
“…kinases (MAPK), extracellular signal-regulated kinases (ERK), and the small GTPases Rac1 and Rap1, resulting in loss of cell-cell contacts, de-stabilization of adherens junctions, and a change in the subcellular localization of cadherins and catenins (Sheibani et al. 2000; Wang and Sheibani 2006).”
BackgroundInfluentialSardjono, C. T., Harbour, S. N., Yip, J., Paddock, C. M., Tridandapani, S., Newman, P. J., & Jackson, D. E. (2006) · Thrombosis and Haemostasis · doi:10.1160/th06-08-0459 · Cited by 39 · cited 2×
“1) where it can act as a regulator of cell signaling and apoptosis (Sardjono et al. 2006).”
BackgroundSelf-citationExpression pattern of alternatively spliced PECAM‐1 isoforms in hematopoietic cells and platelets
Wang, Y., & Sheibani, N. (2002) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10321 · Cited by 35 · cited 2×
“…are expressed in murine tissues, including endothelial cells, lack exon 14 (contains the second cytoplasmic ITIM) (Sheibani et al. 1997; Sheibani et al. 1999; Wang and Sheibani 2002), and thus are not likely to be able to efficiently recruit SHP-2 (Wang and Sheibani 2006; Dimaio and Sheibani 2008).”
BackgroundWang, Y., & Sheibani, N. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20827 · Cited by 35 · cited 5×
“…kinases (MAPK), extracellular signal-regulated kinases (ERK), and the small GTPases Rac1 and Rap1, resulting in loss of cell-cell contacts, de-stabilization of adherens junctions, and a change in the subcellular localization of cadherins and catenins (Sheibani et al. 2000; Wang and Sheibani 2006).”
BackgroundInfluentialWei, H., Lu, F. Y., Chowdhury, S. H., Gong, N., Xiong, Z., Song, J., Mak, K. H., Wu, S., Koay, E. S., Sethi, S. K., et al. (2004) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2004.08.006 · Cited by 35 · cited 1×
“It is also interesting to note that certain single nucleotide polymorphisms (SNP) within PECAM-1 have been associated with a higher risk of coronary artery disease, which is a downstream consequence of atherosclerosis (Wei et al. 2004).”
BackgroundCD31 delays phagocyte membrane repolarization to promote efficient binding of apoptotic cells
Vernon-Wilson, E. F., Aurade, F., Tian, L., Rowe, I. C. M., Shipston, M. J., Savill, J., & Brown, S. B. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0507283 · Cited by 31 · cited 2×
“Finally, PECAM-1 was shown to inhibit membrane repolarization mediated by the ether-a-go-go related gene (ERG) voltage gated potassium channel, which was correlated with enhanced β1-integrin-mediated firm adhesion of phagocytes to apoptotic cells (Vernon-Wilson et al. 2007).”
BackgroundRole for Platelet-Endothelial Cell Adhesion Molecule-1 in Macrophage Fcγ Receptor Function
Albelda, S. Μ., Lau, K. C., Chien, P., Huang, Z.-Y., Arguiris, E., Bohen, A. A., Sun, J., Billet, J. A., Christofidou‐Solomidou, M., Indik, Z. K., et al. (2004) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2003-0404oc · Cited by 29 · cited 15×
“To further investigate these unexpected findings, Schenkel, et al. backcrossed C57BL/6 PECAM-1 knockout mice onto the FVB/n strain, and they showed that these mice did display defects in leukocyte emigration following thioglycollate-induced peritonitis and croton oil-induced topical dermatitis (Schenkel et al. 2004).”
BackgroundInfluentialPECAM-1 isoform-specific functions in PECAM-1-deficient brain microvascular endothelial cells
DiMaio, T. A., & Sheibani, N. (2007) · Microvascular Research · doi:10.1016/j.mvr.2007.10.001 · Cited by 27 · cited 11×
“Other SH2 domain-containing proteins that have been reported to associate with phosphorylated PECAM-1 ITIMs, include members of the Src family of tyrosine kinases (SFK) (Lu et al. 1997; Masuda et al. 1997; Osawa et al. 1997), SHP-1 (Hua et al. 1998; Henshall et al. 2001), SH2 domain-containing inositol 5’-phosphatase…”
BackgroundInfluentialVernon-Wilson, E. F., Aurade, F., & Brown, S. B. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.1005571 · Cited by 23 · cited 1×
“…to be activated downstream of PECAM-1 ligation include the β1- and β2-integrins in T cell subsets (Tanaka et al. 1992), β1integrins in macrophages (Vernon-Wilson et al. 2006; Vernon-Wilson et al. 2007), β2integrins in natural killer (NK) cells (Berman et al. 1996), and the αMβ2 (Mac-1, CD11b/…”
BackgroundShort-term sPECAM-Fc treatment ameliorates EAE while chronic use hastens onset of symptoms
Reinke, E. K., Lee, J., Zozulya, A. L., Kármán, J., Müller, W. A., Sándor, M., & Fábry, Z. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2007.03.014 · Cited by 21 · cited 3×
“N IH -PA Author M anuscript N IH -PA Author M anuscript N IH -PA Author M anuscript Inflammatory Model Results Mousestrain References Leukocyte transmigration across endothelial monolayers PECAM-1 is part of the LBRC, a surface connected membrane compartment, that promotes both paracellular and transcellular migration…”
BackgroundPECAM-Independent Thioglycollate Peritonitis Is Associated With a Locus on Murine Chromosome 2
Seidman, M. A., Chew, T. W., Schenkel, A. R., & Müller, W. A. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004316 · Cited by 21 · cited 1×
“QTL mapping between PECAM-1−/− FVB and C57BL/6 mice has subsequently identified a single locus on chromosome 2 that confers PECAM-1-independent leukocyte transmigration in C57BL/6 mice, though the specific gene(s) remain to be determined (Seidman et al. 2009).”
BackgroundWang, Y., Su, X., Sorenson, C. M., et al. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10451 · Cited by 19 · cited 4×
“…leukocyte-endothelial cell adhesion, leukocyte diapedesis, endothelial junctional stability, and cell survival in both murine and human cells (Sheibani et al. 1997; Sheibani et al. 2000; Wang et al. 2003a; Wang and Sheibani 2006; Kondo et al. 2007; Dimaio and Sheibani 2008; Bergom et al. 2008).”
BackgroundInfluential
Cited by
Endothelial functions of platelet/endothelial cell adhesion molecule-1 (CD31)
Lertkiatmongkol, P., Liao, D., Mei, H., Hu, Y., & Newman, P. J. (2016) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000239 · Cited by 626
Self-citationCoon, B. G., Baeyens, N., Han, J., Budatha, M., Ross, T. D., Fang, J. S., Yun, S., Thomas, J.-L., & Schwartz, M. A. (2015) · Journal of Cell Biology · doi:10.1083/jcb.201408103 · Cited by 299
Diabetic retinopathy: Breaking the barrier
Eshaq, R. S., Aldalati, A. M. Z., Alexander, J. S., & Harris, N. R. (2017) · Pathophysiology · doi:10.1016/j.pathophys.2017.07.001 · Cited by 169
“PECAM-1 is a 130 kDa transmembrane glycoprotein that belongs to the IgG superfamily of receptors with an immunoreceptor tyrosine-like inhibitory motif (ITIM) domain [205].”
BackgroundApoptosis in capillary endothelial cells in ageing skeletal muscle
Wang, H., Listrat, A., Meunier, B., Gueugneau, M., Coudy‐Gandilhon, C., Combaret, L., Taillandier, D., Polge, C., Attaix, D., Lethias, C., et al. (2014) · Aging Cell · doi:10.1111/acel.12169 · Cited by 109
Gröger, M., Rennert, K., Giszas, B., Weiß, E., Dinger, J., Funke, H., Kiehntopf, M., Peters, F. T., Lupp, A., Bauer, M., et al. (2016) · Scientific Reports · doi:10.1038/srep21868 · Cited by 60
Metadata
- Authors
- Privratsky, J. R., Newman, D. K., & Newman, P. J.
- Venue
- Life Sciences
- Publisher
- Elsevier BV
- Published
- 2010-07
- Volume
- 87
- Issue
- 3-4
- Pages
- 69-82
- ISSN
- 0024-3205 (ISSN-L)
- OpenAlex
- W2026252047
- Cited by
- 204
- References
- 109
- FWCI
- 9.92
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.